Basal cell carcinoma secondary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Basal cell carcinoma}} | {{Basal cell carcinoma}} | ||
{{CMG}} {{AE}} Saarah T. Alkhairy, M.D. | {{CMG}} {{AE}} Saarah T. Alkhairy, M.D.,{{M.N}} | ||
==Overview== | ==Overview== | ||
| Line 16: | Line 16: | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | |||
{{WS}} | |||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | [[Category:Oncology]] | ||
[[Category:Medicine]] | [[Category:Medicine]] | ||
[[Category:Dermatology]] | [[Category:Dermatology]] | ||
[[Category:Surgery]] | [[Category:Surgery]] | ||
Latest revision as of 15:24, 6 March 2019
|
Basal cell carcinoma Microchapters |
|
Diagnosis |
|---|
|
Case Studies |
|
Basal cell carcinoma secondary prevention On the Web |
|
American Roentgen Ray Society Images of Basal cell carcinoma secondary prevention |
|
Risk calculators and risk factors for Basal cell carcinoma secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Saarah T. Alkhairy, M.D., Maneesha Nandimandalam, M.B.B.S.[2]
Overview
A skin biopsy and chemotherapeutic agents such as 5-Fluorouracil or Imiquimod may prevent the further development of basal cell carcinoma.
Basal Cell Carcinoma Secondary Prevention
- Skin biopsy
- Chemotherapeutic agents such as 5-Fluorouracil or Imiquimod[1][2]
- It is usually recommended to individuals with extensive sun damage, history of multiple skin cancers, or precancerous growths
- It is often repeated every 2 to 3 years
References
- ↑ Linos E, Katz KA, Colditz GA (October 2016). "Skin Cancer-The Importance of Prevention". JAMA Intern Med. 176 (10): 1435–1436. doi:10.1001/jamainternmed.2016.5008. PMC 5489348. PMID 27459394.
- ↑ Koh, Howard K.; Geller, Alan C. (2004). "Skin cancer prevention comes of age". American Journal of Preventive Medicine. 27 (5): 484–485. doi:10.1016/j.amepre.2004.08.011. ISSN 0749-3797.